| +0.89 / +0.79%|
The 21 analysts offering 12-month price forecasts for Amgen Inc have a median target of 127.63, with a high estimate of 143.00 and a low estimate of 109.00. The median estimate represents a +11.72% increase from the last price of 114.24.
The current consensus among 27 polled investment analysts is to Hold stock in Amgen Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.